Vanguard EM Gov Bnd (VWOB) 81.26 $VWOB 3 Bond ETFs

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vanguard EM Gov Bnd (VWOB) 81.26 $VWOB

3 Bond ETFs Hinting at Emerging Markets Upside
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 09, 5:55AM CDT
If bond markets can forecast gains for equities, then the news should be good for emerging markets stocks and exchange traded funds (ETFs) because the PowerShares Emerging Markets Sovereign Debt Portfolio (NYSEArca: PCY) is on fire. As a...
PCY: 30.54 (+0.06), VWOB: 81.26 (+0.12), EMB: 116.92 (+0.34)

Betting on Russian Bonds With ETFs
ETFtrends.com - ETF Trends - Tue Dec 22, 6:00AM CST
Until recently, Russian stocks and exchange traded funds such as the Market Vectors Russia ETF (NYSEArca: RSX ) had been this year’s star BRIC performers. Next year could bring opportunity for another Russian asset class investors once...
PCY: 30.54 (+0.06), VWOB: 81.26 (+0.12), EMB: 116.92 (+0.34), EMSH: 77.91 (unch)

Emerging Bond ETFs Opportunities Ripen
ETFtrends.com - ETF Trends - Fri Dec 18, 1:00PM CST
Fixed-income exchange traded fund investors who want yield may consider emerging market debt as some observers  believe risks associated with a Federal Reserve interest rate hike have already been priced into the asset category. According to...
EMLC: 18.77 (+0.05), PCY: 30.54 (+0.06), ELD: 37.67 (+0.08), IEF: 111.50 (-0.29), VWOB: 81.26 (+0.12), EMB: 116.92 (+0.34), LEMB: 45.29 (+0.04)

Higher Yielding Emerging Market Bond ETFs Are Outperforming
ETFtrends.com - ETF Trends - Tue Aug 04, 2:07PM CDT
Developing market equities may have fallen off this year. However, emerging market bonds and related exchange traded funds are outperforming U.S. debt, and they come with more attractive yields. Year-to-date, the iShares J.P. Morgan USD Emerging...
PCY: 30.54 (+0.06), IEF: 111.50 (-0.29), LQD: 123.35 (-0.22), EMCB: 71.30 (+0.01), CEMB: 50.77 (-0.04), VWOB: 81.26 (+0.12), EMCD: 30.15 (+0.07), EMB: 116.92 (+0.34)

Investors Turn to Emerging Market Bond ETFs for Higher Yields
ETFtrends.com - ETF Trends - Mon Jun 15, 8:30AM CDT
In the ongoing search for yields during a stubbornly low-rate environment, conservative investors have turned to riskier emerging market debt securities and bond-related exchange traded funds to meet income needs. Year-to-date, the iShares J.P....
PCY: 30.54 (+0.06), VWOB: 81.26 (+0.12), EMB: 116.92 (+0.34)

Shares of VWOB Now Oversold
ETFChannel.com - Fri Jun 05, 10:11AM CDT
In trading on Friday, shares of the Vanguard Emerging Markets Government Bond ETF entered into oversold territory, changing hands as low as $76.82 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a...
VWOB: 81.26 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading